The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
Open Access
- 9 June 2016
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 12 (9) , 2475-2477
Abstract
Demonstration projects or pilots of new public health interventions aim to build learning and capacity to inform country-wide implementation. Authors examined the value of HPV vaccination demonstration projects and initial national programmes in low-income and lower-middle-income countries, including potential drawbacks and how value for national scale-up might be increased. Data from a systematic review and key informant interviews, analyzed thematically, included 55 demonstration projects and 8 national programmes implemented between 2007-2015 (89 years' experience). Initial demonstration projects quickly provided consistent lessons. Value would increase if projects were designed to inform sustainable national scale-up. Well-designed projects can test multiple delivery strategies, implementation for challenging areas and populations, and integration with national systems. Introduction of vaccines or other health interventions, particularly those involving new target groups or delivery strategies, needs flexible funding approaches to address specific questions of scalability and sustainability, including learning lessons through phased national expansion.Keywords
This publication has 7 references indexed in Scilit:
- The Multiple Purposes of Policy Piloting and Their Consequences: Three Examples from National Health and Social Care Policy in EnglandJournal of Social Policy, 2014
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Achieving high coverage in Rwanda’s national human papillomavirus vaccination programmeBulletin of the World Health Organization, 2012
- Human Papillomavirus Vaccination in Tanzanian Schoolgirls: Cluster-Randomized Trial Comparing 2 Vaccine-Delivery StrategiesThe Journal of Infectious Diseases, 2012
- Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countriesBulletin of the World Health Organization, 2011
- Monitoring the coverage and impact of human papillomavirus vaccine - report of WHO meeting, November 2009.2010
- Human papillomavirus vaccines. WHO position paper.2009